Related Experiment Videos
Risk of venous thrombosis with hormone-replacement therapy
J P Vandenbroucke1, F M Helmerhorst
1Department of Clinical Epidemiology, Leiden University Hospital, Netherlands.
Lancet (London, England)
|October 12, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
[Snippets of past medical research: worth saving?].
Nederlands tijdschrift voor geneeskunde·2016
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Journal of thrombosis and haemostasis : JTH·2012
Sex hormone-binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives.
Journal of thrombosis and haemostasis : JTH·2012
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.
Human reproduction (Oxford, England)·2011
Systematic reviews and the needs of the adolescent transgender health care field.
Lancet (London, England)·2026
Pre-eclampsia.
Lancet (London, England)·2026
The effects of androgens on drug metabolism and transport: clinical pharmacologic considerations for people assigned female at birth.
Expert opinion on drug metabolism & toxicology·2026
Three-body problems involving the mother, fetus, and microorganisms.
Immunological medicine·2026
Managing pregnancy in women with pre-existing cardiomyopathies: A case series.
Case reports in women's health·2026